Robert R. Ruffolo
CIK: 0001187308
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Aug 31, 2026ELTX
Elicio Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
21.8K shares- - Jun 3, 2026LBRX
LB PHARMACEUTICALS INC
Award(A)DirectStock Option (Right to Buy)
10K shares- - Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
Award(A)DirectStock Option (Right to Buy)
1.8K shares- - Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
Disposition(D)DirectStock Option (Right to Buy)
717 shares- - Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
Award(A)DirectStock Option (Right to Buy)
717 shares- - Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
Disposition(D)DirectStock Option (Right to Buy)
10.8K shares- - Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
Award(A)DirectStock Option (Right to Buy)
10.8K shares- - Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
Award(A)DirectStock Option (Right to Buy)
22.4K shares- - Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
Disposition(D)DirectStock Option (Right to Buy)
1.8K shares- - May 19, 2025ELTX
Elicio Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
7.9K shares- - Nov 21, 2024ELTX
Elicio Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
4.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 |  ELTX Elicio Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 21,750 | - | - | Direct |
| Jun 3, 2026 |  LBRX LB PHARMACEUTICALS INC | Award(A) Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | Award(A) Stock Option (Right to Buy) | 1,792 | - | - | Direct |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | Disposition(D) Stock Option (Right to Buy) | 717 | - | - | Direct |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | Award(A) Stock Option (Right to Buy) | 717 | - | - | Direct |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | Disposition(D) Stock Option (Right to Buy) | 10,757 | - | - | Direct |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | Award(A) Stock Option (Right to Buy) | 10,757 | - | - | Direct |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | Award(A) Stock Option (Right to Buy) | 22,449 | - | - | Direct |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | Disposition(D) Stock Option (Right to Buy) | 1,792 | - | - | Direct |
| May 19, 2025 | ELTX Elicio Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 7,900 | - | - | Direct |
| Nov 21, 2024 | ELTX Elicio Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 4,100 | - | - | Direct |
1-11 of 11 transactions
About RUFFOLO ROBERT R
RUFFOLO ROBERT R (SEC CIK 0001187308) files insider reports with the SEC as Director of Elicio Therapeutics, Inc. (ELTX) and Director of LB PHARMACEUTICALS INC (LBRX).
Signal8 holds 6 ownership filings by RUFFOLO ROBERT R (1 Form 3, 5 Form 4), filed between Nov 25, 2024 and Sep 2, 2026. Those filings report 11 transactions, from Nov 21, 2024 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on RUFFOLO ROBERT R's filings is in BOSTON, MA.
Recent filings by RUFFOLO ROBERT R
- Aug 31, 2026: Grant or award of ELTX derivative securities (Form 4, code A).
- Jun 3, 2026: Grant or award of LBRX derivative securities (Form 4, code A).
- Sep 10, 2025: Grant or award of LBRX derivative securities (Form 4, code A).
- Sep 10, 2025: Disposition to issuer transaction of LBRX derivative securities (Form 4, code D).
- Sep 10, 2025: Grant or award of LBRX derivative securities (Form 4, code A).
Other insiders filing for Elicio Therapeutics, Inc. (ELTX)
- ADAMS JULIAN, Director
- Ashe Carol Gail, Director
- Chudnovsky Yekaterina, Director
- Nissenson Allen, Director
- WILSON KAREN J, Director
- Venkatesan Jay, Director